Column Capital Advisors’s Ingevity NGVT Stock Holding History

Column Capital Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14	Closed	–	–	804
2020 Q2	$0	Hold	14	–	–	﹤0.01%	886
2020 Q1	$0	Hold	14	–	–	﹤0.01%	769
2019 Q4	$1K	Buy	+14	New	+$1.22K	﹤0.01%	677

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Column Capital Advisors's NGVT Position: Q3 2020 in Review

Column Capital Advisors sold out of Ingevity (NGVT) in Q3 2020, closing a stake of 14 shares.

Column Capital Advisors first reported a position in NGVT in Q4 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 283 funds tracked by Wall St. Rank hold NGVT as of Q3 2020.

Column Capital Advisors reported no remaining Ingevity position as of Q3 2020 after selling out during the quarter.
Column Capital Advisors sold 14 Ingevity shares in Q3 2020.
Column Capital Advisors first reported a position in Ingevity in Q4 2019 and held it in 3 quarters.
Column Capital Advisors's Ingevity position peaked at $1K in Q4 2019.
283 funds tracked by Wall St. Rank held Ingevity as of Q3 2020.

Based on Column Capital Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.